Owing to the large size of the ELSA-Brasil study, we were not able to assess insulin resistance and secretion using more sophisticated methods, and thus relied on the relatively more crude plasma insulin levels and HOMA measurements. The gene discussed is INS; the disease is Insulin resistance.